Review
Copyright ©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Jun 10, 2011; 2(6): 262-271
Published online Jun 10, 2011. doi: 10.5306/wjco.v2.i6.262
Figure 2
Figure 2 Comparison of overall survival with the most frequently given regimens in first-line treatment of metastatic non small cell lung carcinoma. 1Scagliotti et al[7]; 2Pirker et al[20]; 3Sandler et al[14]. HR: Hazard ratio; OS: Overall survival.